Literature-based Discovery of New Candidates for Drug Repurposing
Overview
Affiliations
Drug development is an expensive and time-consuming process; these could be reduced if the existing resources could be used to identify candidates for drug repurposing. This study sought to do this by text mining a large-scale literature repository to curate repurposed drug lists for different cancers. We devised a pattern-based relationship extraction method to extract disease-gene and gene-drug direct relationships from the literature. These direct relationships are used to infer indirect relationships using the ABC model. A gene-shared ranking method based on drug target similarity was then proposed to prioritize the indirect relationships. Our method of assessing drug target similarity correlated to existing anatomical therapeutic chemical code-based methods with a Pearson correlation coefficient of 0.9311. The indirect relationships ranking method achieved a significant mean average precision score of top 100 most common diseases. We also confirmed the suitability of candidates identified for repurposing as anticancer drugs by conducting a manual review of the literature and the clinical trials. Eventually, for visualization and enrichment of huge amount of repurposed drug information, a chord diagram was demonstrated to rapidly identify two novel indications for further biological evaluations.
Genomic strategies for drug repurposing.
Dave K, Patel D, Dave N, Jain M J Egypt Natl Canc Inst. 2024; 36(1):35.
PMID: 39523244 DOI: 10.1186/s43046-024-00245-z.
DDCM: A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm.
Xu M, Li W, He J, Wang Y, Lv J, He W Int J Mol Sci. 2024; 25(10).
PMID: 38791306 PMC: 11121335. DOI: 10.3390/ijms25105267.
Enhancing the coverage of SemRep using a relation classification approach.
Ming S, Zhang R, Kilicoglu H J Biomed Inform. 2024; 155:104658.
PMID: 38782169 PMC: 11770837. DOI: 10.1016/j.jbi.2024.104658.
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing.
Makeeva V, Dyrkheeva N, Lavrik O, Zakian S, Malakhova A Int J Mol Sci. 2023; 24(23).
PMID: 38069121 PMC: 10706709. DOI: 10.3390/ijms242316798.
Yang H, Chien M, Chiang J, Lin P Comput Struct Biotechnol J. 2022; 20:5287-5295.
PMID: 36212540 PMC: 9519430. DOI: 10.1016/j.csbj.2022.09.025.